{"id":"https://openalex.org/W3107345101","doi":"https://doi.org/10.1681/asn.2020050595","title":"Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial","display_name":"Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial","publication_year":2020,"publication_date":"2020-12-03","ids":{"openalex":"https://openalex.org/W3107345101","doi":"https://doi.org/10.1681/asn.2020050595","mag":"3107345101","pmid":"https://pubmed.ncbi.nlm.nih.gov/33272965","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7894678"},"language":"en","primary_location":{"id":"doi:10.1681/asn.2020050595","doi":"https://doi.org/10.1681/asn.2020050595","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.2020050595","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7894678","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046497650","display_name":"Pablo E. P\u00e9rgola","orcid":"https://orcid.org/0000-0002-5876-894X","observed_orcids":["https://orcid.org/0000-0002-5876-894X"]},"institutions":[{"id":"https://openalex.org/I4210157924","display_name":"Renal Associates P. A.","ror":"https://ror.org/04wc1v131","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210157924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pablo E. Pergola","raw_affiliation_strings":["Renal Associates, P.A., San Antonio, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renal Associates, P.A., San Antonio, Texas","institution_ids":["https://openalex.org/I4210157924"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103167469","display_name":"Matt Devalaraja","orcid":"https://orcid.org/0000-0003-1531-0303","observed_orcids":["https://orcid.org/0000-0003-1531-0303"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matt Devalaraja","raw_affiliation_strings":["Corvidia Therapeutics, Inc., Waltham, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corvidia Therapeutics, Inc., Waltham, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052481605","display_name":"Steven Fishbane","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven Fishbane","raw_affiliation_strings":["Division of Nephrology, Department of Medicine, Donald and Barbara Zucker School of Medicine, Great Neck, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology, Department of Medicine, Donald and Barbara Zucker School of Medicine, Great Neck, New York","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110182882","display_name":"Michel Chonchol","orcid":"https://orcid.org/0000-0001-6195-1318","observed_orcids":["https://orcid.org/0000-0001-6195-1318"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michel Chonchol","raw_affiliation_strings":["Division of Renal Medicine Disease and Hypertension, University of Colorado, Aurora, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Renal Medicine Disease and Hypertension, University of Colorado, Aurora, Colorado","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058965585","display_name":"Vandana S. Mathur","orcid":"https://orcid.org/0000-0003-3089-8205","observed_orcids":["https://orcid.org/0000-0003-3089-8205"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vandana S. Mathur","raw_affiliation_strings":["Mathur Consulting, Woodside, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mathur Consulting, Woodside, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mark T. Smith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark T. Smith","raw_affiliation_strings":["Nephrology Associates, Augusta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nephrology Associates, Augusta, Georgia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000542177","display_name":"Larry Lo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Larry Lo","raw_affiliation_strings":["Corvidia Therapeutics, Inc., Waltham, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corvidia Therapeutics, Inc., Waltham, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kurt Herzog","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kurt Herzog","raw_affiliation_strings":["Corvidia Therapeutics, Inc., Waltham, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corvidia Therapeutics, Inc., Waltham, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085395543","display_name":"Rahul K. Kakkar","orcid":"https://orcid.org/0000-0003-1273-0441","observed_orcids":["https://orcid.org/0000-0003-1273-0441"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rahul Kakkar","raw_affiliation_strings":["Pandion Therapeutics, Inc., Waltham, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pandion Therapeutics, Inc., Waltham, Massachusetts","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055380940","display_name":"Michael Davidson","orcid":"https://orcid.org/0000-0002-4698-1719","observed_orcids":["https://orcid.org/0000-0002-4698-1719"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael H. Davidson","raw_affiliation_strings":["Corvidia Therapeutics, Inc., Waltham, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corvidia Therapeutics, Inc., Waltham, Massachusetts","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.8878,"has_fulltext":false,"cited_by_count":85,"citation_normalized_percentile":{"value":0.97273069,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"32","issue":"1","first_page":"211","last_page":"222"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10291","display_name":"Dialysis and Renal Disease Management","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anemia-of-chronic-disease","display_name":"anemia of chronic disease","score":0.9570000171661377},{"id":"https://openalex.org/keywords/hemodialysis","display_name":"hemodialysis","score":0.9490000009536743},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.7419999837875366},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.828000009059906},{"id":"https://openalex.org/keywords/il-6-receptor-inhibition","display_name":"IL-6 receptor inhibition","score":0.6309999823570251},{"id":"https://openalex.org/keywords/hepcidin","display_name":"hepcidin","score":0.8420000076293945},{"id":"https://openalex.org/keywords/erythropoiesis-stimulating-agents","display_name":"erythropoiesis-stimulating agents","score":0.9670000076293945},{"id":"https://openalex.org/keywords/iron-metabolism","display_name":"iron metabolism","score":0.7519999742507935},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.6060000061988831},{"id":"https://openalex.org/keywords/serum-albumin","display_name":"serum albumin","score":0.7720000147819519},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.9110000133514404},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.6909999847412109}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8801710605621338},{"id":"https://openalex.org/C2778063415","wikidata":"https://www.wikidata.org/wiki/Q391744","display_name":"Hemodialysis","level":2,"score":0.8064333200454712},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.7465482950210571},{"id":"https://openalex.org/C2776768029","wikidata":"https://www.wikidata.org/wiki/Q14882371","display_name":"Hepcidin","level":3,"score":0.7119930386543274},{"id":"https://openalex.org/C2781404941","wikidata":"https://www.wikidata.org/wiki/Q2178381","display_name":"Darbepoetin alfa","level":3,"score":0.6712241768836975},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.6028438806533813},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5848008394241333},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5570623278617859},{"id":"https://openalex.org/C2779703530","wikidata":"https://www.wikidata.org/wiki/Q837174","display_name":"Erythropoiesis","level":3,"score":0.5107653141021729},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5086184740066528},{"id":"https://openalex.org/C2779978075","wikidata":"https://www.wikidata.org/wiki/Q202301","display_name":"Dialysis","level":2,"score":0.4803713262081146},{"id":"https://openalex.org/C2778534260","wikidata":"https://www.wikidata.org/wiki/Q218706","display_name":"Erythropoietin","level":2,"score":0.4584940969944},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.415760338306427},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09980335831642151},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000093242","descriptor_name":"Interleukin-6 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006397","descriptor_name":"Hematinics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006435","descriptor_name":"Renal Dialysis","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012709","descriptor_name":"Serum Albumin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D064451","descriptor_name":"Hepcidins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1681/asn.2020050595","doi":"https://doi.org/10.1681/asn.2020050595","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.2020050595","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7894678","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7894678","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Am Soc Nephrol","raw_type":"Text"},{"id":"pmid:33272965","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33272965","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology : JASN","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:7894678","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7894678","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Am Soc Nephrol","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1715452167","https://openalex.org/W1899490312","https://openalex.org/W1970727081","https://openalex.org/W1973938903","https://openalex.org/W1981428755","https://openalex.org/W1990220461","https://openalex.org/W1995768948","https://openalex.org/W1998943227","https://openalex.org/W2008979953","https://openalex.org/W2010494541","https://openalex.org/W2033803279","https://openalex.org/W2040029744","https://openalex.org/W2049912996","https://openalex.org/W2050241533","https://openalex.org/W2051969301","https://openalex.org/W2060595107","https://openalex.org/W2082855795","https://openalex.org/W2097586983","https://openalex.org/W2111249486","https://openalex.org/W2117757710","https://openalex.org/W2120650829","https://openalex.org/W2130082562","https://openalex.org/W2144758554","https://openalex.org/W2151301696","https://openalex.org/W2294763393","https://openalex.org/W2580449060","https://openalex.org/W2584947097","https://openalex.org/W2900365689","https://openalex.org/W2973305257","https://openalex.org/W2974852979","https://openalex.org/W2979769504","https://openalex.org/W3040354040","https://openalex.org/W4231314771"],"related_works":["https://openalex.org/W4389672505","https://openalex.org/W4396994282","https://openalex.org/W4403761353","https://openalex.org/W7143045910","https://openalex.org/W4403830896","https://openalex.org/W3023963910","https://openalex.org/W1904419816","https://openalex.org/W4212826390","https://openalex.org/W3183414613","https://openalex.org/W4306254391"],"abstract_inverted_index":{"Significance":[0],"Statement":[1],"Patients":[2,133],"with":[3,39,57,134,182,216,288,336,385],"CKD":[4,135],"who":[5,136],"are":[6,9,137,140],"on":[7,59,130,138,180,256,383],"hemodialysis":[8,139,181,384],"hyporesponsive":[10,141],"to":[11,33,85,142,195,198,221,310,389,400],"erythropoiesis-stimulating":[12,143],"agents":[13,144],"(ESAs)":[14,145],"because":[15,146],"of":[16,18,24,47,73,102,118,128,147,149,160,171,188,227,282,299,312,372,407,410],"anemia":[17,94,148],"inflammation":[19,58,386],"mediated":[20],"by":[21,318],"IL-6\u2013induced":[22],"expression":[23,155],"hepcidin,":[25],"an":[26,103,122],"iron":[27,109,210,258,359],"regulatory":[28],"hormone.":[29],"Reducing":[30],"ESA":[31,41,76,208,243,315,351,375,390],"usage":[32,316],"decrease":[34],"ESA-related":[35],"cardiovascular":[36,90],"risk,":[37],"especially":[38],"high":[40],"doses,":[42],"is":[43,156,193],"a":[44,66,86,157,173,184,203,283],"clinical":[45],"goal":[46],"nephrologists.":[48],"In":[49],"this":[50],"randomized,":[51],"phase":[52,165],"1/2":[53],"trial":[54,168],"in":[55,88,125,178,275,326,339,381],"patients":[56,129,179,215,272,289,382],"hemodialysis,":[60],"the":[61,100,113,126,189,276,327,340,402],"authors":[62],"show":[63],"that":[64,106,192],"ziltivekimab,":[65,172],"novel":[67,174],"anti\u2013IL-6":[68,175],"ligand":[69,176],"antibody,":[70,177],"reduced":[71,374],"markers":[72,371],"inflammation,":[74,99,257,373],"decreased":[75,317,350],"usage,":[77],"and":[78,111,209,254,262,278,306,330,354,364,377,387,396,405],"increased":[79,355,378],"serum":[80,260,303,356,365,379],"albumin,":[81,261],"which":[82],"might":[83],"lead":[84],"reduction":[87],"overall":[89],"risk.":[91],"Because":[92],"current":[93],"treatments":[95],"do":[96],"not":[97],"reduce":[98],"availability":[101],"anti-inflammatory":[104],"therapy":[105],"also":[107,344],"improves":[108],"utilization":[110],"reduces":[112],"need":[114],"for":[115,238,349],"escalating":[116],"doses":[117],"ESAs":[119],"could":[120],"represent":[121],"important":[123],"advancement":[124],"care":[127],"hemodialysis.":[131,242],"Background":[132],"inflammation.":[150,162],"Interleukin-6":[151],"(IL-6)":[152],"induced":[153],"hepcidin":[154],"key":[158],"mediator":[159],"such":[161],"Methods":[163],"This":[164],"1/2,":[166],"placebo-controlled":[167],"assessed":[169],"effects":[170,255],"rs855791,":[183],"single":[185],"nucleotide":[186],"polymorphism":[187],"TMPRSS6":[190],"gene":[191],"hypothesized":[194],"heighten":[196],"susceptibility":[197],"IL-6\u2013mediated":[199],"inflammatory":[200],"effects.":[201],"After":[202],"screening":[204],"period":[205],"documenting":[206],"stable":[207],"dosing,":[211],"we":[212],"randomized":[213],"61":[214],"elevated":[217],"IL-6":[218],"(\u22654":[219],"pg/ml)":[220],"receive":[222],"placebo":[223,341],"or":[224,230,321],"ziltivekimab":[225,294,332],"(doses":[226],"2,":[228],"6,":[229],"20":[231],"mg),":[232],"administered":[233],"intravenously":[234],"every":[235],"2":[236],"weeks":[237,240],"12":[239],"during":[241],"dose":[244,347],"adjustments":[245],"were":[246],"allowed":[247],"after":[248],"4":[249],"weeks.":[250],"We":[251,343],"analyzed":[252],"safety":[253],"metabolism,":[259],"anti-drug":[263],"antibodies.":[264],"Results":[265],"No":[266],"patient":[267,325],"experienced":[268,295],"dose-limiting":[269],"toxicity.":[270],"Four":[271],"(two":[273],"each":[274],"6-":[277],"20-mg":[279,331],"cohorts)":[280],"died":[281],"treatment-emergent":[284],"adverse":[285],"event.":[286],"Compared":[287],"receiving":[290,293],"placebo,":[291],"those":[292],"significantly":[296,369],"greater":[297],"reductions":[298],"high-sensitivity":[300],"C-reactive":[301],"protein,":[302],"amyloid":[304],"A,":[305],"fibrinogen":[307],"from":[308],"baseline":[309],"end":[311],"treatment.":[313],"Median":[314],"15,000,":[319,320],"33,000":[322],"IU/wk":[323],"per":[324],"2-,":[328],"6-,":[329],"cohorts,":[333],"respectively,":[334],"compared":[335],"no":[337],"change":[338],"group.":[342],"noted":[345],"significant":[346],"responses":[348],"resistance":[352],"index":[353],"iron,":[357],"total":[358],"binding":[360],"capacity,":[361],"transferrin":[362],"saturation,":[363],"albumin.":[366],"Conclusions":[367],"Ziltivekimab":[368],"improved":[370],"requirements,":[376],"albumin":[380],"hyporesponsiveness":[388],"therapy.":[391],"Clinical":[392],"Trial":[393],"registry":[394],"name":[395],"registration":[397],"number":[398],"Study":[399],"Assess":[401],"Safety,":[403],"Pharmacokinetics,":[404],"Pharmacodynamics":[406],"Multiple":[408],"Doses":[409],"COR-001,":[411],"NCT02868229":[412]},"counts_by_year":[{"year":2026,"cited_by_count":16},{"year":2025,"cited_by_count":15},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-12-07T00:00:00"}